Germany: Coverage for Diabetes, Not Obesity Germany presents a contrasting picture
Obesity can be a chronic, relapsing disease
Patients can minimise nausea by: Eating smaller, more frequent meals rather than large portions Avoiding high-fat, greasy, or spicy foods Staying well hydrated throughout the day Taking the tablet on an empty stomach as directed, without food that might interfere with absorption Other side effects that may occur include: Dyspepsia (indigestion) and gastro-oesophageal reflux Flatulence and bloating Hypoglycaemia (low blood sugar), particularly when used with insulin or sulfonylureas While rare, serious adverse reactions can occur at any dose and patients should seek urgent medical attention if they experience: Severe, persistent abdominal pain that may radiate to the back (potential pancreatitis) Symptoms of gallbladder disease (sudden pain in upper abdomen, particularly right side) Signs of dehydration from persistent vomiting or diarrhoea, which may lead to acute kidney injury Symptoms of hypoglycaemia that do not resolve with usual measures Allergic reactions such as rash, swelling, or difficulty breathing Patients with pre-existing diabetic retinopathy should be monitored closely, as rapid improvements in blood glucose control may temporarily worsen retinopathy
The average time to plateau is 43.2 weeks
Our experts can easily help you in this process
Both options are excellent, but Tirzepatides dual-action approach gives it an edge in hunger control and weight loss
